1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Genetic architecture of oral glucose-stimulated insulin release provides biological insights into type 2 diabetes aetiology
- Contribution to journal › Article
- 2013
-
Mark
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes
- Contribution to journal › Article
- 2011
-
Mark
A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes
- Contribution to journal › Article
-
Mark
Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study
- Contribution to journal › Article
- 2010
-
Mark
Genetic association analysis of LARS2 with type 2 diabetes
- Contribution to journal › Article
- 2009
-
Mark
The diabetes risk score outperforms fasting plasma glucose and glucose tolerance tests: combined results from the Inter99 and Botnia Studies
(2009) 45th Annual Meeting of the European-Association-for-the-Study-of-Diabetes In Diabetologia 52(Suppl 1). p.7-7
- Contribution to journal › Published meeting abstract
-
Mark
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men
- Contribution to journal › Article
-
Mark
Functional SOCS1 polymorphisms are associated with variation in obesity in whites
- Contribution to journal › Article
- 2007
-
Mark
Impact of the peroxisome proliferator activated receptor-gamma coactivator-1 beta (PGC-1 beta) Ala203Pro polymorphism on in vivo metabolism, PGC-1 beta expression and fibre type composition in human skeletal muscle
- Contribution to journal › Article
-
Mark
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial
- Contribution to journal › Article
